Legend Biotech Corporation - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Legend Biotech Corporation - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US52490G1022

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Legend Biotech Corporation - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 59 75 80 89 93 69 119 96 106 117 112 165 233 285 343 456 520 627 728 797
Change (%) 27.80 7.20 10.57 5.15 -26.37 72.31 -19.39 10.80 10.46 -4.27 47.01 41.69 22.22 20.22 33.02 14.08 20.58 16.11 9.41
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 232 71 313 10 481 611 401 440 483 492 526 562 596 608 648 666 699
Change (%) -69.39 -96.72 4,578.41 27.04 -34.33 9.76 9.65 1.94 6.99 6.69 6.16 1.96 6.62 2.71 4.99
% of Revenue 309.55 88.40 455.27 8.66 502.79 576.49 342.73 392.97 293.13 210.88 184.62 163.84 130.76 116.86 103.33 91.40 87.71
Gross Operating Profit 59 -157 9 89 93 -245 108 -385 -505 -284 -328 -318 -259 -241 -219 -140 -88 -21 63 98
Change (%) -367.81 -105.93 853.09 5.15 -361.60 -144.30 -455.49 31.07 -43.73 15.55 -3.09 -18.65 -6.73 -9.31 -35.91 -37.46 -76.19 -399.81 56.41
% of Revenue 100.00 -209.55 11.60 100.00 100.00 -355.27 91.34 -402.79 -476.49 -242.73 -292.97 -193.13 -110.88 -84.62 -63.84 -30.76 -16.86 -3.33 8.60 12.29
SG&A 55 73 85 97 113 150 161 181 192 174 180 184 191 201 217 233 264 284 301 316
Change (%) 32.70 16.78 14.09 16.53 32.44 7.88 12.08 5.95 -9.12 3.56 2.05 3.86 5.17 7.96 7.48 13.02 7.87 5.73 5.07
% of Revenue 93.36 96.94 105.60 108.97 120.77 217.22 136.00 189.08 180.81 148.75 160.92 111.71 81.88 70.47 63.28 51.13 50.66 45.32 41.27 39.63
R&D 231 184 285 294 313 -155 -227
Change (%) 54.82 3.04 -149.32 46.80
% of Revenue 394.18 229.05 320.74 314.30 264.22 -161.64 -214.16
OpEx 286 305 340 381 406 463 485 508 576 575 620 667 683 727 779 829 871 932 966 1,015
Change (%) 6.61 11.57 12.06 6.63 13.89 4.76 4.71 13.36 -0.09 7.89 7.44 2.47 6.48 7.04 6.53 5.07 7.00 3.63 5.01
% of Revenue 487.30 406.49 423.05 428.76 434.80 672.49 408.89 531.11 543.38 491.48 553.90 404.84 292.77 255.09 227.12 181.89 167.52 148.65 132.67 127.34
Operating Income -227 -230 -260 -292 -313 -394 -366 -412 -470 -458 -508 -502 -450 -442 -436 -373 -351 -305 -238 -218
Change (%) 1.14 12.99 12.52 7.08 25.91 -7.03 12.51 13.95 -2.47 10.99 -1.27 -10.40 -1.68 -1.46 -14.31 -5.94 -13.12 -22.03 -8.44
% of Revenue -387.30 -306.49 -323.05 -328.76 -334.80 -572.49 -308.89 -431.11 -443.38 -391.48 -453.90 -304.84 -192.77 -155.09 -127.12 -81.89 -67.52 -48.65 -32.67 -27.34
Interest Expense -4 -0 -1 -2 -3 -7 -11 -15 -18 -21 -22 -22 -22 -22 -22 -21 -21
Change (%) -95.42 106.22 88.42 86.93 65.15 38.15 23.41 13.19 4.60 1.66 1.26 -0.68 -3.00 -1.92 -1.17
% of Revenue -7.25 -0.26 -1.31 -1.57 -3.66 -6.17 -9.23 -13.32 -11.18 -8.93 -7.64 -6.46 -4.92 -4.28 -3.45 -2.91 -2.63
Net Income -310 -266 -340 -297 -356 -404 -346 -457 -416 -446 -517 -532 -509 -518 -466 -285 -348 -177 -218 -325
Change (%) -13.96 27.70 -12.73 19.82 13.46 -14.17 31.82 -8.86 7.25 15.91 2.84 -4.28 1.76 -10.09 -38.83 22.14 -49.15 23.23 49.13
% of Revenue -527.56 -355.16 -423.07 -333.94 -380.55 -586.38 -292.09 -477.64 -392.91 -381.48 -461.89 -323.13 -218.30 -181.75 -135.92 -62.50 -66.92 -28.22 -29.95 -40.83

Source: Capital IQ

Other Listings
DE:9LB € 30.80
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista